Under the deal, Shivom will offer Family Care Path's MyLegacy web-based clinical decision support application through its online app marketplace.
After giving up on the cryptocurrency idea, LunaDNA looks to "invert the research equation" by letting patients control and sell their genomic and health information.
Blockchain-based startup EncrypGen will take advantage of Murrieta Genomics' sequencing lab and business services to market its Gene-Chain platform for data sharing.
Shivom and Lifebit will offer an artificial intelligence-based platform for identifying the right patients for enrollment in clinical trials.
The startup plans to use blockchain to enable genomic data sharing and will partner with Veritas to gain access to its open-source software platform.
The year-old German company wants to help the healthcare industry decentralize genomic data with its platform for potentially billions of people worldwide.
Israeli firm DNATix recently claimed not only the transfer of a genetic sequence using blockchain technology, but the transfer of a complete Y chromosome.
The company intends to use the proceeds for, among other things, investigating the use of blockchain technology in medicine and biotechnology.
Nonprofit eMQT will use Shivom's decentralized blockchain platform to store and share genomic data of sickle-cell diseases in underserved regions.
Indian DTC genomics company Mapmygenome has enlisted Israel-based Digital DNAtix to move its interpretation and personalized medicine services to a blockchain.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.